Related Experiment Video
Updated: Aug 11, 2026

06:25
Stereoacuity Improvement using Random-Dot Video Games
Published on: January 14, 2020
Risk Factors for Stereoacuity Impairment in Intermittent Exotropia: Results from a Nationwide Korean Study
Dong Cheol Lee1, Soochul Park2, Songhee Park3
1Department of Ophthalmology, Keimyung University, School of Medicine, Daegu, Korea.
Korean Journal of Ophthalmology : KJO
|August 10, 2026
Summary
Anisometropia significantly impairs stereoacuity in intermittent exotropia (IXT). Maintaining fusion control is crucial for good vision, while prematurity and low birth weight have minimal impact.
Area of Science:
- Ophthalmology
- Strabismus Research
- Binocular Vision
Background:
- Intermittent exotropia (IXT) is a common strabismus affecting binocular vision.
- Stereoacuity, a key component of visual function, can be impaired in IXT patients.
- Identifying factors influencing stereoacuity is crucial for effective management.
Purpose of the Study:
- To identify clinical factors associated with stereoacuity impairment in patients with intermittent exotropia (IXT).
- To investigate the influence of perinatal, refractive, motor, and sensory parameters on stereoacuity in IXT.
Main Methods:
- A nationwide cross-sectional study of 5,385 Korean patients with IXT was conducted (Korean Intermittent Exotropia Multicenter Study - KIEMS).
- Stereoacuity was assessed using Titmus and Randot stereotests.
- Multivariable logistic regression identified predictors, including anisometropia and Worth 4 Dot (W4D) categories.
Main Results:
- Anisometropia (≥1.5 D) was strongly linked to poor Titmus stereoacuity (OR=4.707).
- Good distance and near fusion control were protective factors for Titmus stereoacuity.
- Prematurity and low birth weight were not independently associated with stereoacuity.
Conclusions:
- Anisometropia and fusion control are significant predictors of stereoacuity in IXT.
- Preserving fusion control and correcting anisometropia are vital for maintaining binocular visual function in IXT patients.
